StreetInsider.com News Articles

Quarterback Amends Twin Gold Project Option Agreement

Mon, 21 Sep 2026 19:27:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 21, 2026) - Quarterback Resources Inc. (CSE: QB) (FSE: H89) ("Quarterback" or the "Company") is pleased to announce that it has entered into a property option amending agreement concerning the Twin Gold Project. Under the terms of the amending agreement, the Company must make $75,000 in cash payments to the optionor in stages by November 30, 2026; fund exploration expenditures on the Project of $150,000 (now funded) and an additional $350,000 by March 1, 2027; and issue 500,000 common shares to the optionor by March 1, 2027. The remainder of the commitments in the

Quarterback Amends Twin Gold Project Option Agreement

Mon, 21 Sep 2026 19:27:00 -0400

Guided Therapeutics receives $80,000 installment from Chinese distributor

Wed, 22 Jul 2026 09:00:19 -0400

Guided Therapeutics, Inc. (OTCQB: GTHP) announced it received an $80,000 payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT), representing the fourth installment of a $700,000 purchase order placed by the Chinese distributor.

According to the company's press release, four LuViva Advanced Cervical Scan devices are expected to ship later this year, bringing the total number of devices shipped to 11 of the 35 devices due under the agreement. HDMT operates in Hangzhou City, Zhejiang Province, where it serves as the exclusive gynecology products provider for 42 hospitals that conduct approximately two million cervical cancer screenings annually.

Guided Therapeutics also noted a

Guided Therapeutics receives $80,000 installment from Chinese distributor

Wed, 22 Jul 2026 09:00:19 -0400

Guided Therapeutics also noted a

Guided Therapeutics receives $80,000 installment from Chinese distributor

Wed, 22 Jul 2026 09:00:19 -0400

Guided Therapeutics also noted a

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

Wed, 22 Jul 2026 09:00:00 -0400

The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

Wed, 22 Jul 2026 09:00:00 -0400

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

Wed, 22 Jul 2026 09:00:00 -0400

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

Wed, 22 Jul 2026 09:00:00 -0400

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

Wed, 22 Jul 2026 09:00:00 -0400

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

Wed, 22 Jul 2026 09:00:00 -0400

Guided Therapeutics signs new China distribution deal for LuViva device

Tue, 14 Jul 2026 09:03:21 -0400

Guided Therapeutics, Inc. (OTCQB: GTHP) announced a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply LuViva Advanced Cervical Scan instruments, single-use components, and support services in China.

Under the agreement, Guided Therapeutics will receive payments and parts from China valued at approximately $300,000. Upon approval by China's National Medical Products Administration (NMPA), the company will execute a purchase order for 50 LuViva systems and 500,000 single-use components. In return, Guided Therapeutics will provide services and specialized parts needed for a manufacturing inspection by the NMPA. A successful inspection is expected to lead to NMPA approval for marketing and sale

Guided Therapeutics signs new China distribution deal for LuViva device

Tue, 14 Jul 2026 09:03:21 -0400

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

Tue, 14 Jul 2026 09:00:00 -0400

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

Tue, 14 Jul 2026 09:00:00 -0400

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

Tue, 14 Jul 2026 09:00:00 -0400

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

Tue, 14 Jul 2026 09:00:00 -0400

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

Tue, 14 Jul 2026 09:00:00 -0400

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

Tue, 14 Jul 2026 09:00:00 -0400

Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor